Angiotensin converting enzyme inhibitors and angiotensin II AT1 receptor antagonists (sartans) used in the secondary prevention of cardiovascular events, comparison of basic data

Abstract

The review summarizes the most important pharmacological characteristics and clinical data of renin-angiotensin-aldosterone system blockers, which can be used in the secondary prevention of cardiovascular events. Positive influence on the prognosis of patients has been demonstrated in large randomized studies with ramipril, perindopril, trandolapril, and telmisartan.

Keywords

• secondary prevention
• cardiovascular events
• renin-angiotensin-aldosterone system
• ramipril
• perindopril
• trandolapril